BMC Medical Co. Ltd. A (301367) - Total Assets
Based on the latest financial reports, BMC Medical Co. Ltd. A (301367) holds total assets worth CN¥3.52 Billion CNY (≈ $515.61 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See BMC Medical Co. Ltd. A (301367) shareholders funds for net asset value and shareholders' equity analysis.
BMC Medical Co. Ltd. A - Total Assets Trend (2020–2024)
This chart illustrates how BMC Medical Co. Ltd. A's total assets have evolved over time, based on quarterly financial data.
BMC Medical Co. Ltd. A - Asset Composition Analysis
Current Asset Composition (December 2024)
BMC Medical Co. Ltd. A's total assets of CN¥3.52 Billion consist of 91.6% current assets and 8.4% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 15.3% |
| Accounts Receivable | CN¥186.46 Million | 5.4% |
| Inventory | CN¥102.41 Million | 3.0% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥5.87 Million | 0.2% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2020–2024)
This chart illustrates how BMC Medical Co. Ltd. A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see BMC Medical Co. Ltd. A (301367) total market value.
Key Asset Composition Facts
- Current vs. Non-Current Assets: BMC Medical Co. Ltd. A's current assets represent 91.6% of total assets in 2024, a decrease from 93.1% in 2020.
- Cash Position: Cash and equivalents constituted 15.3% of total assets in 2024, down from 46.7% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2020.
- Asset Diversification: The largest asset category is accounts receivable at 5.4% of total assets.
BMC Medical Co. Ltd. A Competitors by Total Assets
Key competitors of BMC Medical Co. Ltd. A based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087
|
China | CN¥12.14 Billion |
|
Vizionfocus Inc.
TW:4771
|
Taiwan | NT$6.53 Billion |
|
MEDIMI AB AK
F:79T
|
Germany | €1.70 Million |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.32 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$272.48 Million |
|
SDI Ltd
AU:SDI
|
Australia | AU$141.20 Million |
|
Austco Healthcare Ltd
AU:AHC
|
Australia | AU$91.07 Million |
|
Trajan Group Holdings Ltd
AU:TRJ
|
Australia | AU$192.32 Million |
BMC Medical Co. Ltd. A - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.57 | 14.02 | 29.19 |
| Quick Ratio | 5.38 | 13.44 | 27.65 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥2.66 Billion | CN¥2.62 Billion | CN¥2.69 Billion |
BMC Medical Co. Ltd. A - Advanced Valuation Insights
This section examines the relationship between BMC Medical Co. Ltd. A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.32 |
| Latest Market Cap to Assets Ratio | 0.25 |
| Asset Growth Rate (YoY) | 17.3% |
| Total Assets | CN¥3.42 Billion |
| Market Capitalization | $869.67 Million USD |
Valuation Analysis
Below Book Valuation: The market values BMC Medical Co. Ltd. A's assets below their book value (0.25x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: BMC Medical Co. Ltd. A's assets grew by 17.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for BMC Medical Co. Ltd. A (2020–2024)
The table below shows the annual total assets of BMC Medical Co. Ltd. A from 2020 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥3.42 Billion ≈ $501.16 Million |
+17.35% |
| 2023-12-31 | CN¥2.92 Billion ≈ $427.07 Million |
-0.28% |
| 2022-12-31 | CN¥2.93 Billion ≈ $428.28 Million |
+369.26% |
| 2021-12-31 | CN¥623.69 Million ≈ $91.27 Million |
+33.37% |
| 2020-12-31 | CN¥467.64 Million ≈ $68.43 Million |
-- |
About BMC Medical Co. Ltd. A
BMC Medical Co., Ltd. researches, develops, manufactures, and supplies medical equipment and consumable in the field of respiratory health in China. It offers sleep-disordered breathing (SDB) diagnostic devices, non-invasive ventilators, high-flow nasal cannula oxygen therapy devices, oxygen concentrator, and respiratory consumables, such as various types of masks, breathing tubes, etc., as well … Read more